PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 25, 2026Cellular and Molecular Life Sciences0 citationsOpen Access

NR5A2 controls gene expression and chromatin contacts of essential circadian metabolic genes in the liver

ARAbraham Román-FigueroaJGJuan Carlos Gómora‐GarcíaLTLuis Tenorio-Hernández

Key Points

  • This research aims to understand how NR5A2 regulates circadian gene expression and chromatin interactions in liver metabolism.
  • Conducted genome-wide analysis to identify NR5A2 binding sites and dynamics of enhancer-promoter interactions.
  • Utilized high-resolution 4C-seq to observe chromatin looping between metabolic gene promoters and enhancers.
  • Applied pharmacological inhibition of NR5A2 in vivo to assess impact on hepatic metabolic processes.
  • NR5A2 binds H3K27ac-enriched enhancers, with maximal enhancer-promoter interactions at Zeitgeber time 0 (ZT0).
  • Pharmacological inhibition of NR5A2 resulted in altered hepatic glycogen and cholesterol levels.
  • Attenuated rhythmic expression of metabolic genes, including Ppp1r3c, Cyp8b1, and Elovl5, was observed.

Abstract

Circadian regulation of gene expression relies on the coordinated action of core clock components, tissue-specific transcription factors, and epigenetic mechanisms, including dynamic enhancer–promoter interactions. Although rhythmic chromatin looping has been described in the liver, the transcription factors that mediate these temporal interactions remain poorly defined. Here, we identify the nuclear receptor NR5A2 as a key regulator of circadian enhancer–promoter communication in the mouse liver. We show that NR5A2 protein levels fluctuate over the 24-h cycle, peaking around Zeitgeber time 0 (ZT0). Genome-wide analysis reveals that NR5A2 preferentially binds H3K27ac-enriched enhancer regions, many of which engage in chromatin looping with promoters of metabolic genes. High-resolution 4C-seq analyses demonstrate that promoters of Elovl5 and Ppp1r3c dynamically interact with NR5A2- and H3K27ac-enriched enhancers in a time-dependent manner, with maximal interactions at ZT0 and reduced contacts at ZT12. Pharmacological inhibition of NR5A2 in vivo leads to alterations in hepatic glycogen and cholesterol accumulation, attenuates the rhythmic expression of circadian metabolic genes, including Ppp1r3c, Cyp8b1, and Elovl5, and disrupts enhancer–promoter contact frequencies at the Elovl5 locus. Together, our findings provide in vivo evidence that NR5A2 integrates circadian and metabolic regulation by modulating enhancer–promoter chromatin interactions, thereby shaping rhythmic liver gene expression.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Román-Figueroa et al. (2026) studied this question.

synapsesocial.com/papers/6a13e83b0e02ee3982d32e5ahttps://doi.org/10.1007/s00018-026-06250-w
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PPP1R6, a novel member of the family of glycogen‐targetting subunits of protein phosphatase 11997 · 109 citations
  2. 2Transitions in chromatin conformation shaped by fatty acids and the circadian clock underlie hepatic transcriptional reorganization in obese mice2024 · 4 citations
  3. 3A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathology2023 · 85 citations
  4. 4peakC: a flexible, non-parametric peak calling package for 4C and Capture-C data2018 · 118 citations
  5. 5Intervene: a tool for intersection and visualization of multiple gene or genomic region sets2017 · 612 citations